Tag: venture capital
-
Univ. Spin-Off Developing Myelin Disease Treatments Unveiled
A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders.
-
A.I. Drug Discovery Company Gains $32M in Early Funds
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round.
-
New $315 Million Life Sciences Venture Fund Unveiled
A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe.
-
Bacterial Genome Recoded to Produce Stable Protein Drugs
A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods.
-
Infographic – Graphene Investment in Decline
In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out.
-
Genetic Repair Company Starts-Up, Gains $87 Million
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA.
-
Genentech Gains Microbe Drug Discovery Tech in $1B Deal
Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil.
-
Infographic – Google Health Care Investments Take Off
One indicator of Google’s expanding involvement in health care is its venture investments in digital health and health technology start-ups, which is this weekend’s infographic.
-
New Cell Therapy Company Raises $58.5M in Early Funds
A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health.
-
New Company Acquires Off-the-Shelf T-Cell Cancer Therapies
A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells.